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A B S T R A C T
Inﬁltration of leukocytes within the vessel at sites of inﬂammation and the subsequent generation of myelo-
peroxidase-derived oxidants, including hypochlorous acid, are key characteristics of atherosclerosis.
Hypochlorous acid is a potent oxidant that reacts readily with most biological molecules, including DNA and
RNA. This results in nucleic acid modiﬁcation and the formation of diﬀerent chlorinated products. These pro-
ducts have been used as biomarkers of inﬂammation, owing to their presence in elevated amounts in diﬀerent
inﬂammatory ﬂuids and diseased tissue, including atherosclerotic lesions. However, it is not clear whether these
materials are simply biomarkers, or could also play a role in the development of chronic inﬂammatory
pathologies. In this study, we examined the reactivity of diﬀerent chlorinated nucleosides with human coronary
artery endothelial cells (HCAEC). Evidence was obtained for the incorporation of each chlorinated nucleoside
into the cellular RNA or DNA. However, only 8-chloro-adenosine (8ClA) had a signiﬁcant eﬀect on the cell
viability and metabolic activity. Exposure of HCAEC to 8ClA decreased glycolysis, and resulted in a reduction in
ATP, with a corresponding increase in the chlorinated analogue, 8Cl-ATP in the nucleotide pool. 8ClA also
induced sustained endoplasmic reticulum stress within the HCAEC, which resulted in activation of the unfolded
protein response, the altered expression of antioxidant genes and culminated in the release of calcium into the
cytosol and cell death by apoptosis. Taken together, these data provide new insight into pathways by which
myeloperoxidase activity and resultant hypochlorous acid generation could promote endothelial cell damage
during chronic inﬂammation, which could be relevant to the progression of atherosclerosis.
1. Introduction
Chronic inﬂammation and the inﬁltration and activation of leuko-
cytes within the vessel wall, play a central role in the development of
lesions and progression of atherosclerosis [1]. This results in the release
of myeloperoxidase (MPO) and the overproduction of oxidants, parti-
cularly hypochlorous acid (HOCl), at inﬂammatory sites [2]. HOCl is
highly reactive, and can induce the oxidation and modiﬁcation of a
wide range of biomolecules including proteins, lipids, RNA, and DNA
[2]. This causes localised damage to the surrounding cells and tissue
[3], and has been implicated in the development of numerous in-
ﬂammatory pathologies, particularly atherosclerosis [4], where ele-
vated levels of MPO are also a risk factor [5] and prognostic marker for
patient outcome [6].
The reaction of HOCl with RNA and DNA forms both unstable
chloramines (N–Cl species) [7] and stable chlorinated products,
including 8-chloro-adenosine (8ClA), 8-chloro-guanosine (8ClG), 5-
chloro-cytidine (5ClC), 8-chloro-2′-deoxyadenosine (8CldA), 8-chloro-
2′-deoxyguanosine (8CldG), 5-chloro-2′-deoxycytidine (5CldC) and 5-
chloro-uracil (5ClU) [8–12]. A number of these stable products have
been detected in elevated amounts in the urine, plasma, inﬂammatory
ﬂuids or the diseased tissues of patients with diﬀerent pathological
conditions [9,13,14], including atherosclerosis [15]. Although chlori-
nated nucleosides are recognised as biomarkers, it is not well under-
stood as to whether these materials can also play a role in promoting
the progression of chronic inﬂammatory disease.
It is well established that the incorporation of chlorinated nucleo-
sides into DNA is mutagenic [16–18], which implicates these com-
pounds as playing a role in the development of inﬂammatory cancers
[19,20]. Somewhat paradoxically, this ability of chlorinated nucleo-
sides to modify cellular DNA and RNA has also been utilised ther-
apeutically in order to kill malignant cells. For example, 5CldC has been
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used as a sensitizing agent, to increase the amount of damage induced
during radiation therapy [21], while the toxicity of 8ClA in many cell
types, including chronic lymphocytic leukemia lymphocytes [22],
breast cancer [23], myeloma [24] and mantle cell lymphoma cells [25]
has led to clinical trials to test its eﬃcacy as a chemotherapeutic drug.
In the malignant cell types examined, 8ClA was reported to induce
apoptotic cell death by either inhibiting the transcription of anti-
apoptotic proteins or through reducing the concentration of in-
tracellular ATP [22–24]. In each case, 8ClA is phosphorylated by var-
ious enzymes, including adenosine kinase, to 8Cl-ATP (the ATP ana-
logue of 8ClA) [24,26,27]. Previous studies with malignant cells are
typically performed with 8ClA concentrations of 10 μM [25–28], which
is believed to be a therapeutically achievable plasma concentration
based on data from previous animal studies with 8ClA [29] and clinical
trials with 8-Cl-cAMP [30]. However, the levels of 8ClA formed during
chronic inﬂammation, and whether 8ClA can inﬂuence the function of
non-malignant cells, or inﬂuence cellular homeostasis by other path-
ways and potentially propagate the progression of disease remain un-
clear.
In cells, the endoplasmic reticulum (ER) is responsible for the
folding, synthesis, modiﬁcation and quality control of a variety of
proteins. Many stresses to the ER can cause dysregulation including the
activation of inﬂammatory pathways, the depletion of Ca2+, oxidative
stress and hypoxia [31]. Prolonged ER stress leads to the activation of
the unfolded protein response (UPR), which is a major pathway gov-
erning apoptotic cell death within the inﬂammatory environment that
characterises an atherosclerotic lesion [32,33]. In particular, cell death
mediated by the UPR has been implicated in endothelial damage,
atherosclerotic plaque instability as well as in the clinical progression of
atherosclerosis [32,34]. Furthermore, activation of the UPR has also
been associated with the alteration of cellular antioxidant defence
systems and other stress-related signalling pathways within cells [35].
In this study, we examined the ability of a series of model chlori-
nated nucleosides, including 5Cl(d)C, 8Cl(d)G, and 8Cl(d)A to in-
corporate into the RNA and DNA of human coronary artery endothelial
cells (HCAEC) and inﬂuence cellular metabolic activity and viability. Of
particular note was the sensitivity demonstrated by HCAEC in response
to exposure to 8ClA. Therefore, additional studies were performed to
examine the eﬀects of this chlorinated nucleoside on stress-related
signaling cascades and antioxidant responses within the cells, including
ER stress and related pathways, which could play a role in propagating
disease progression under chronic inﬂammatory conditions.
2. Materials and methods
Materials: All aqueous reagents were prepared using nanopure
water (npH2O) ﬁltered through a four-stage milli-Q system. All reagents
were from Sigma-Aldrich (Castle Hill, NSW, Australia) unless otherwise
noted. Chlorinated nucleosides (8ClA; 8CldA; 5ClC; 5CldC; 8ClG;
8CldG) were obtained from BioLog Life Sciences Institute (Bremen,
Germany) and reconstituted in npH2O to a stock concentration of
500 μM before storage at −80 °C. Nucleosides for experimental treat-
ments were prepared by diluting stock solutions into complete
MesoEndo cell culture medium (Cell Applications) and ﬁltered through
Millex® GP 0.22 μm syringe ﬁlters to remove any contaminants prior to
addition to cells.
Cell culture: HCAEC (Cell Applications, San Diego, CA, USA) from
a minimum of 3 individual donors were cultured in MesoEndo cell
culture medium (Cell Applications) under sterile conditions in 175 cm2
tissue culture ﬂasks in humidiﬁed 5% CO2 at 37 °C. For experiments,
cells were prepared by enzymatic dissociation using trypsin-EDTA to
form a cell suspension which was normalised to 5×104 cells/mL. Cells
between passages 3 and 6, were plated in MesoEndo cell culture
medium allowed to adhere overnight prior to treatment. HCAEC were
exposed to chlorinated nucleosides at varying concentrations (4, 8,
16 μM) for 2, 6, 24, 48 and 72 h. For PERK inhibition studies, HCAEC
were pre-incubated with 10 μM GSK2606414 (Merck) for 1 h prior to
treatment with 8ClA, with adenosine (Ad) used in analogous experi-
ments as a non-chlorinated control for 8ClA.
Detection of chlorinated nucleosides in RNA and DNA:
Following exposure of HCAEC to nucleosides, the cellular RNA and
DNA were extracted using an Isolate II RNA/DNA/Protein Kit (Bioline)
following manufacturer's instructions and normalised to 500 ng RNA or
DNA per reaction and hydrolysed using 2 U Nuclease P1 (Sigma-
Aldrich) with incubation for 2 h at 37 °C. Samples were then depho-
sphorylated with 10 U alkaline phosphatase (Sigma-Aldrich) for 1 h at
37 °C prior to liquid-liquid extraction with chloroform. Samples were
subjected to centrifugal ﬁltration through 10 kDa and 0.22 μm ﬁlters
(Merck), before solid phase extraction using C18 cartridges (Waters).
Chromatographic separation of parent and chlorinated nucleosides was
achieved using a Discovery C18 column (5 μm pore size,
25 cm×2.1mm) (Sigma-Aldrich). A 20 μL injection of each sample
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was eluted at a ﬂow rate of 0.2 mL/min using 5mM ammonium formate
in H2O (Buﬀer A) and 5mM ammonium formate in 50% (v/v) acet-
onitrile (Buﬀer B). A gradient elution was performed, with an isocratic
hold at 100% Buﬀer A for 10min, a linear gradient to 20% Buﬀer B over
40min, 50% Buﬀer B over 10min and to 100% Buﬀer B in 5min where
buﬀer composition remained for 5min before re-equilibration to 100%
Buﬀer A over the next 5min prior to injection of the next sample
(adapted from Ref. [11]). Detection of nucleosides was achieved by UV
absorbance at 260 nm (Agilent Technologies 1290 Inﬁnity) and by
positive ESI triple-quadrupole mass spectrometry (Agilent Technologies
6490). Nitrogen was used as the collision gas with source and sheath
gas temperatures at 290 and 400 °C, respectively. Mass fragmentation
was monitored as previously published [11,36]. The amount of
chlorinated product was normalised 1:1000 to parent nucleoside.
Metabolic activity: The metabolic activity of treated cells was
analysed using Prestoblue Cell Viability Reagent (Thermo Fisher
Scientiﬁc) as per manufacturer's instructions. HCAEC were plated at
5× 104 cells/mL overnight and exposed to chlorinated nucleosides (4,
8, 16 μM) for 24 and 48 h at 37 °C with 5% CO2. 2 h prior to the end of
the exposure period, the reagent was added to each sample. Once the 24
or 48 h time point was completed, the change in ﬂuorescence was
measured at excitation of 560 nm and emission of 590 nm using a
SpectraMax M2e Microplate Reader (Molecular Devices).
Quantiﬁcation of ATP and 8Cl-ATP in the nucleotide pool:
HCAEC were lysed with Milli-Q water before nucleotide pool extraction
twice using perchloric acid (0.4M) and centrifuging to remove cell
debris [37]. The supernatant was neutralised to pH 7 by addition of
KOH (on ice) and ﬁltered through a 0.2 μm centrifugal ﬁlter before
separation using HPLC with a ZORBAX SAX column (5 μm
4.6×250mm; Agilent). 50 μL injections were eluted at a ﬂow rate of
1.5 mL/min from an initial mobile phase composition of 60% 5mM
ammonium phosphate (pH 2.8) and 40% 0.75M ammonium phosphate
(pH 3.6) to a ﬁnal composition of 100% 0.75M ammonium phosphate
(pH 3.6), over 65min. Eluents were detected with UV absorbance at
254 nm using a SPD-M20A detector. ATP was also quantiﬁed by lumi-
nescence using the ATPlite assay system (PerkinElmer). HCAEC (1 x
104) were plated overnight in black 96 well plates before exposure to
8ClA for 48 h at 37 °C with 5% CO2. Following treatment, the cells were
washed and lysed using the cell lysis solution provided, before addition
of the substrate solution and dark adapting the plate for 10min as per
the manufacturer's instructions. The luminescence was recorded using a
SpectraMax M2e Microplate Reader (Molecular Devices).
Oxidative phosphorylation and glycolysis: Oxygen consumption
rate (OCR) and extracellular acidiﬁcation rate (ECAR) were analysed
using a Seahorse XF24 Extracellular ﬂux analyser and the cell Mito
stress test kit (Agilent). HCAEC were washed with Seahorse XF DMEM
supplemented with 20mM glucose, 40 μM L-glutamine and 80 μM so-
dium pyruvate after treatment with 8ClA. OCR was measured at 37 °C,
in the absence and following sequential injection of inhibitors: oligo-
mycin (1.7 μM), carbonyl cyanide-p-triﬂuoromethoxyphenylhydrazone
(FCCP, 0.7 μM) and rotenone/antimycin A (0.5 μM). ECAR was mea-
sured in HCAEC washed with Seahorse XF DMEM supplemented with
40 μM L-glutamine followed by incubation at 37 °C and an injection of
10mM glucose into each sample. Each sample was normalised to pro-
tein, quantiﬁed using the DC protein assay (BioRad). To conﬁrm the
extent of glycolysis, the glycolysis cell-based assay kit (Cayman
Chemical) was used to measure the secretion of L-lactate into the ex-
tracellular media.
Glucose uptake: The uptake of glucose was assessed using the
Glucose Uptake Cell-Based Assay Kit (Cayman Chemical) in HCAEC
exposed to 8ClA or Ad (8 μM) for 48 h. Cell culture media was then
removed and replaced with glucose free HBSS with or without apigenin
(50 μM) followed by incubation for 1 h. The ﬂuorescent glucose analog
2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)-amino]-D-glucose
(NBDG, 250 μM) was then added and incubated for 20min. Supernatant
was removed and replaced with Cell-Based Assay buﬀer. The change in
ﬂuorescence was then detected using a SpectraMax M2e Microplate
Reader (Molecular Devices) at an excitation and emission of 485 and
535 nm, respectively.
Enzymatic activity of GAPDH: HCAEC were lysed in water fol-
lowing treatment with the nucleosides and washing with PBS to remove
cell media. The lysates were added to a solution of NAD+ (20mM) in
45mM sodium pyrophosphate/60mM sodium phosphate (pH 7.4)
buﬀer. Immediately prior to analysis, glyceraldehyde 3-phosphate
(180 μM) was added to each sample to start the reaction with the for-
mation of NADH determined by absorbance at 340 nm, monitored at
37 °C over time using a SpectraMax M2e Microplate Reader (Molecular
Devices) with activity normalised to protein concentration determined
using the bicinchoninic acid (BCA) assay.
Quantitative real-time polymerase chain reaction (qPCR) for
mRNA expression: RNA was extracted using ReliaPrep RNA Cell
Miniprep System (Promega), then quantiﬁed using a Nanodrop 2000C
Spectrophotometer (Thermo Scientiﬁc). RNA concentrations were
normalised to 500 ng/reaction, with reverse transcription performed
using the iScript cDNA synthesis kit and thermo-cycling at 25 °C for
5min, 42 °C for 30min, 85 °C for 5min and inﬁnite hold at 4 °C. cDNA
was then diluted 1:3 before qPCR using iQ SYBR Green supermix
(BioRad). Each sample was then heated to 95 °C for 3min, annealed at
60 °C for 30 s extended for 30 s at 72 °C, over 40 cycles, with dena-
turation at 95 °C for 2min. At the end of each cycle, a dissociation curve
at 0.5 °C intervals between 65 °C and 95 °C was plotted. Each sample
was compared to Ct values obtained from a standard curve from 1:10
serial dilutions of cDNA for each primer and normalised to two
housekeeping genes, 18S ribosomal RNA and RPL13. Primer sequences
of the housekeeping and target genes are listed in Supplementary
Table 1.
Protein expression and Western blotting: HCAEC were lysed
using the cell lytic reagent (Sigma-Aldrich) containing 1% (v/v) pro-
tease inhibitors, then separated into cytoplasmic and nuclear fractions
using the NE-PER Nuclear and Cytosolic extraction kit (Thermo Fisher
Scientiﬁc). Protein concentration was normalised using the BCA assay.
Samples were loaded onto 4–12% Bis-tris gels (Life Technologies) and
transferred onto iBlot 2 PVDF membrane (Thermo Fisher Scientiﬁc).
The membrane was then blocked in 5% (w/v) BSA in Tris-buﬀered
saline containing 0.1% Tween-20 (TBST; 20mM Tris-HCl, pH 7.4,
135mM NaCl, 0.1% (v/v) Tween) for 2 h prior to incubation with
1:1000 anti-ATF4 primary antibody or anti-TXNIP primary antibody for
2 h. A 1:2000 dilution anti-rabbit IgG in 5% (w/v) BSA in TBST (Cell
Signaling Technology) was then added and incubated at 21 °C for 1 h.
The membrane was imaged by chemiluminescence using Western
Lighting – plus ECL (PerkinElmer). Ponceau S staining or a β-actin
primary antibody was used to conﬁrm equal protein loading across the
Western blot.
Flow cytometry: For apoptosis and necrosis studies, HCAEC were
resuspended in Annexin V binding buﬀer (10mM HEPES, 140mM
NaCl, 2.5mM CaCl2, pH 7.4) prior to addition of Annexin V-APC (BD
Biosciences) and propidium iodide (Sigma-Aldrich). Each sample was
then vortexed and incubated in the dark at 37 °C, 5% CO2 for 15min.
For calcium release into the cytosol, HCAEC were resuspended in 5 μM
Fluo-4AM (Thermo Fisher Scientiﬁc) in calcium-free HBSS for 45min in
the dark at 37 °C, 5% CO2. Samples were stored on ice prior to analysis
using a FACSVerse ﬂow cytometer (BD Biosciences).
Statistical analyses: Statistical analyses were performed using
GraphPad Prism software 7.0 (GraphPad Software, San Diego, USA)
using one-way or two-way ANOVA with appropriate multiple compar-
ison post-hoc tests with p < 0.05 taken as signiﬁcant as outlined in the
Figure Legends.
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3. Results
3.1. Incorporation of chlorinated nucleosides into the cellular RNA and
DNA
Initial studies were performed to determine the extent of in-
corporation of each chlorinated nucleoside into the RNA and DNA of
HCAEC over 72 h. Exposure of HCAEC to the chlorinated ribose nu-
cleosides 8ClA, 8ClG and 5ClC (16 μM, 0.16 pmol/cell) resulted in their
incorporation into the cellular RNA in a nucleoside and time-dependent
manner (Fig. 1A–C). The incorporation of 8ClA increased over 24 h,
with this nucleoside found to incorporate at higher levels in the RNA
compared to 8ClG and 5ClC, which were also incorporated but reached
maximal levels in the RNA by 6 h of treatment (Fig. 1A–C). Treatment
of HCAEC with the chlorinated deoxyribose nucleosides 8CldA, 8CldG
and 5CldC (16 μM, 0.16 pmol/cell) resulted in their incorporation into
the cellular DNA (Fig. 1D–F). In this case, the maximal incorporation of
each nucleoside was achieved at 48 h, with 8CldG found to incorporate
to a greater extent compared to 8CldA and 5CldC (Fig. 1D–F). There
was no chlorination of the RNA or DNA detected in the control cells,
which were incubated in the absence of each chlorinated nucleoside.
In each case, there was no signiﬁcant change in the concentration of
the parent nucleosides, or any evidence for the incorporation of ribose
nucleosides into DNA and deoxyribose nucleosides into RNA (data not
shown). Further experiments were performed to examine whether the
concentration of chlorinated nucleoside present in the RNA or DNA was
altered in the absence of an exogenous source of 8Cl(d)A, 8Cl(d)G or
5Cl(d)C. In these experiments, the HCAEC were treated with each in-
dicated chlorinated nucleoside for 24 h, before washing the cells, and
re-culturing in the absence of the chlorinated nucleoside for a further
48 h. In general, there was no signiﬁcant diﬀerence in the extent of
incorporation of each chlorinated nucleoside following the washing and
Fig. 1. The incorporation of chlorinated
nucleosides into cellular RNA and DNA.
HCAEC (1×106 cells) were treated with A)
8ClA, B) 8ClG, C) 5ClC, D) 8CldA, E) 8CldG
and F) 5CldC (16 μM; 0.16 pmol/cell) for
2–72 h (grey bars) or 24 h with washing to
remove exogenous chlorinated nucleosides
and re-incubation of the cells in normal cell
media for 48 h (white bars, labelled
24 + 48), before extraction, hydrolysis and
dephophorylation of the RNA and DNA and
analysis by LC-MS. The concentration of
chlorinated nucleoside was normalised to
the respective parent nucleoside and is ex-
pressed as a 1:1000 ratio. Data are the
mean ± SEM samples from at least three
independent cell donors. *, ** and **** re-
present a signiﬁcant (p < 0.05, 0.01 and
0.0001) diﬀerence in the level of chlori-
nated nucleosides compared to the re-
spective non-treated controls, with a, b, and
c showing a signiﬁcant (p < 0.05) diﬀer-
ence on comparing the 24 + 48 sample
with the 24 h, 48 h or 72 h samples re-
spectively, as determined by 1-way ANOVA
with the Sidak multiple comparison post-
hoc test.
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48 h re-incubation, compared to that observed on analysis immediately
after 24–72 h incubation (Fig. 1, white bars, labelled 24 + 48). How-
ever, exceptions to this behaviour were observed with 8ClA, where a
decrease in 8ClA within the RNA was observed on re-incubation com-
pared to the 24 h treatment (Fig. 1A), and 8CldG, where a decrease was
observed compared to the 48 and 72 h treatments. A decrease, albeit
non-signiﬁcant, was also seen in cells exposed to 5ClC and 5CldC
(Fig. 1C,F).
These data are consistent with the removal of the 8ClA (and possibly
5ClC) from the RNA, which did not appear to be the case with 8ClG.
With 8CldG, the concentration of this nucleoside in the DNA was si-
milar at 24 h to that seen at 24 h with further re-incubation in the ab-
sence of 8CldG. This suggests that there is little clearance of this nu-
cleoside, with additional incorporation seen on longer incubation times
in the presence of 8CldG, though less incorporation is apparent at 72 h
compared to 48 h. There is also a marked, but non-signiﬁcant, decrease
in the concentration of 5CldC within the DNA following re-incubation
compared to that seen at 24 h. There was some variation in the pattern
and extent of chlorinated nucleoside incorporation in some cases be-
tween the individual HCAEC donors, resulting in a large error asso-
ciated with these analyses.
3.2. 8ClA decreases metabolic activity and glycolysis in HCAEC
The metabolic activity of HCAEC was determined after exposure to
chlorinated nucleosides (4, 8 and 16 μM) for 24 h (Fig. 2A) and 48 h
(Fig. 2B) using the Prestoblue assay. An alteration in metabolic activity
compared to the non-treated, control, cells was only apparent in HCAEC
exposed to 8ClA, with no signiﬁcant changes seen with the other
chlorinated nucleosides (Fig. 2). The decrease in metabolic activity
observed with 8ClA treatment was greater following 48 h (Fig. 2B) ra-
ther than 24 h (Fig. 2A), and was independent of the concentration of
8ClA used, with a similar loss in activity observed in experiments with
4, 8 and 16 μM 8ClA. These diﬀerences in metabolic activity were not
observed in the analogous experiments with non-chlorinated adenosine
controls (data not shown).
It is well established that 8ClA can be metabolised to form the
chlorinated analogue of ATP, 8Cl-ATP in malignant cell types, which
can lead to a decrease in the production of ATP [24,26,27]. Therefore,
the ratio of ATP to 8Cl-ATP was assessed by HPLC following extraction
of the nucleotide pool of HCAEC treated with 8ClA (8 μM) for 24 h.
Evidence was obtained for the formation of 8Cl-ATP on treatment of the
HCAEC with 8ClA but not in control experiments with adenosine
(Fig. 3B). The formation of 8Cl-ATP was associated with a small, but
non-signiﬁcant decrease in ATP (Fig. 3A). In addition, there was no
signiﬁcant change in the concentration of GTP, CTP or UTP on treat-
ment of HCAEC with either 8ClA or adenosine treatment (Suppl. Fig.
S1). Studies were extended to examine the concentration of ATP fol-
lowing exposure of the HCAEC to 8ClA for 48 h, where a more pro-
nounced change in metabolic activity was seen. In this case, a decrease
in ATP was observed in the HCAEC, which was signiﬁcant in experi-
ments with 16 μM (0.16 pmol/cell) 8ClA, whereas no change in ATP
was seen on treatment with non-chlorinated adenosine (Fig. 3C).
Given 8ClA treatment of HCAEC decreased the metabolic activity of
the cells and endogenous ATP concentration, studies were extended to
examine mitochondrial respiration using a Seahorse analyser to mea-
sure changes in OCR following a mitochondrial stress test, where oli-
gomycin, FCCP and rotenone/antimycin A are added in series to inhibit
ATP production, uncouple the mitochondria and inhibit the electron
transport chain (ETC), respectively. HCAEC were treated with 8ClA (4,
8 and 16 μM) or adenosine (16 μM) for 48 h, where a signiﬁcant de-
crease in metabolic activity was observed (Fig. 2B). However, there
were no diﬀerences in the basal respiration of the cells (no inhibitors),
the ATP coupler response (with oligomycin), the ETC accelerator re-
sponse (with FCCP), coupling eﬃciency, spare respiratory capacity or
non-mitochondrial respiration (with rotenone/antimycin A) in the
presence of 8ClA or adenosine compared to the control non-treated cells
(Fig. 4 and Suppl. Fig. S2). Taken together, these data suggest that 8ClA
treatment does not have a signiﬁcant eﬀect on the mitochondrial pro-
duction of ATP.
The eﬀect of 8ClA on the glycolytic activity of the HCAEC was also
examined using a Seahorse analyser to measure changes in ECAR on
stimulation of the cells with glucose (10mM). There were no diﬀer-
ences in the baseline ECAR readings of the HCAEC under any of the
treatment conditions, which were recorded in the absence of glucose
(Fig. 5A). However, on injection of glucose, a marked decrease in the
ECAR was seen in the HCAEC exposed to 8ClA, compared to the ade-
nosine or non-treated cells (Fig. 5A and B). This is consistent with 8ClA
treatment resulting in a decrease in the glycolytic activity of the
HCAEC. These data were supported by measuring the concentration of
lactate (the end-product of glycolysis) secreted into the extracellular
environment, which was signiﬁcantly decreased in cells treated with
8ClA (Fig. 5C).
The uptake of glucose by the HCAEC in the presence and absence of
8ClA was examined using the ﬂuorescent glucose analog NBDG.
However, no changes in the glucose uptake were apparent after ex-
posure of the HCAEC to 8ClA compared to the adenosine or non-treated
cells (Suppl. Fig. S3). This was in contrast to experiments were HCAEC
were treated with apigenin (50 μM), a known inhibitor of Glut-1, where
a decrease in the uptake of NBDG was observed (Suppl. Fig. S3). As the
decrease in glycolysis was not related to altered glucose uptake, these
studies were extended to measure the activity of the glycolytic enzyme
GADPH. Exposure of HCAEC to 8ClA (8 μM) for 48 h resulted in a sig-
niﬁcant (35%) decrease in the activity of GAPDH compared to that
observed in the non-treated control cells (Fig. 5D). A less marked, but
statistically signiﬁcant decrease in GAPDH activity was also observed
Fig. 2. The eﬀect of chlorinated nucleosides on metabolic activity. HCAEC
(1×104 cells) were treated each chlorinated nucleoside (4, 8, 16 μM) for A)
24 h or B) 48 h before assessing metabolic activity by conversion of the re-
sazurin-based PrestoBlue® reagent to ﬂuorescent resoruﬁn at λex= 560 nm and
λem = 590 nm. Results represent the mean ± SEM of multiple experiments
with at least 3 independent cell donors. * and ** show a signiﬁcant (p < 0.05
and 0.01) change in metabolic activity compared to the non-treated control by
two-way ANOVA with the Dunnett's multiple comparison post-hoc test.
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on treatment of the cells with adenosine (Fig. 5D). The reason for this is
not certain, given that adenosine treatment does not result in signiﬁcant
changes in either the ECAR or lactate release to the extracellular media.
3.3. 8ClA induces ER stress, alters the cellular antioxidant responses and
promotes apoptotic cell death in HCAEC
Given the marked eﬀect of 8ClA on cellular metabolism, these stu-
dies were extended to examine alterations in the expression of genes
associated with stress-related signalling pathways. Evidence was ob-
tained for a signiﬁcant increase in both the mRNA expression and nu-
clear translocation of ATF4 in HCAEC treated with 8ClA (Fig. 6A,B,C),
which was also observed on treatment of the cells with tunicamycin, a
known inducer of the UPR [30] (Fig. 6A and B). There was also a sig-
niﬁcant increase in the expression of other UPR-associated genes
downstream of ATF4, including growth arrest DNA damage inducible
34 (GADD34) and CCAAT-enhancer-binding protein homologous pro-
tein (CHOP) (Fig. 6D and E). Treatment of HCAEC with 8ClA also in-
creased the mRNA expression of spliced x-box binding protein 1
(sXBP1; Fig. 6F), which is a marker reﬂecting IRE1 and ATF6 signalling
in response to ER stress [38]. These changes in mRNA expression were
not observed in the corresponding experiments with adenosine (Fig. 6).
ER stress is associated with the induction of cellular antioxidant
responses, particularly the Nrf2-Keap1 signalling pathway [35].
Therefore, these studies were extended to examine the eﬀect of 8ClA
treatment on the expression of a range of antioxidant genes. Incubation
of HCAEC with 8ClA (8 μM) for 24 h resulted in a signiﬁcant increase in
the mRNA expression of NADPH dehydrogenase quinone 1 (NQO1),
heme oxygenase 1 (HO-1), and glutamate-cysteine ligase catalytic
subunit (GCLC), which supports activation of Nrf2 (Fig. 7A–C). Simi-
larly, there was a signiﬁcant increase in both the mRNA and protein
expression of thioredoxin interacting protein (TXNIP; Fig. 7D,E,F),
which lends further support to a role of 8ClA in the induction of cellular
stress. However, under these experimental conditions, there were no
changes in the mRNA expression of other antioxidant genes, including
SOD1, SOD2, glutathione peroxidase 4 (GPx4), thioredoxin (Trx) or
glutathione synthase (GS) (Suppl. Fig. S4). In each case, there was also
no change in mRNA expression on treatment of the HCAEC with non-
chlorinated adenosine (Fig. 6, Suppl. Fig. S4).
Prolonged ER stress results in alterations to the intracellular calcium
storage and apoptotic cell death. Therefore, the release of calcium from
the ER into the cytosol was assessed in HCAEC treated with 8ClA using
ﬂow cytometry with Fluo-4AM staining. Treatment of the HCAEC with
8ClA (8 μM) for 24 h resulted in a signiﬁcant increase to 1.5-fold of the
non-treated control in cytosolic calcium (Fig. 8A, Suppl. Fig. S5). This
increase in cytosolic calcium was not observed on pre-treatment of the
HCAEC with a pharmacological inhibitor of PERK (10 μM
GSK2606414), prior to exposure to 8ClA (Fig. 8B). Similarly, ﬂow cy-
tometry analysis with Annexin V and propidium iodide staining showed
that treatment of HCAEC with 8ClA (8 μM) for 48 and 72 h resulted in a
signiﬁcant decrease in the population of viable cells and corresponding
increase in the population of Annexin V positive cells, which was not
seen with the adenosine or non-treated cells (Fig. 8C and D, Suppl. Fig.
S6). With 8ClA treatment, a small, but not signiﬁcant, increase in the
cells containing propidium iodide was also observed, consistent with
some necrotic cell death (Fig. 8C and D). Taken together, these data are
Fig. 3. Treatment of HCAEC with 8ClA results in 8Cl-ATP formation. (A)
and (B) HCAEC (6× 105 cells) were treated with 8ClA (8 μM) or adenosine
(8 μM) for 24 h before quantifying the concentration of ATP (A) and 8Cl-ATP
(B) in the cellular nucleotide pool following extraction with perchloric acid and
separation by HPLC. (C) HCAEC (1×104 cells) were treated with 8ClA
(4–16 μM) or adenosine (16 μM) for 48 h with ATP quantiﬁed using the ATPlite
assay. Data represent the mean ± SEM of multiple replicates with at least 2
independent cell donors. * shows a signiﬁcant (p < 0.05) change compared to
the non-treated control samples by one-way ANOVA with Dunnett's multiple
comparison post-hoc test.
Fig. 4. The eﬀect of 8ClA on mitochondrial respiration. The change in mi-
tochondrial respiration of HCAEC (3.2× 104 cells) treated with 8ClA (4, 8,
16 μM) or adenosine (16 μM) for 48 h was determined by measuring the OCR
using a Seahorse XF Analyser with the sequential addition of oligomycin
(1.7 μM), FCCP (0.7 μM) and rotenone/antimycin A (0.5 μM). The results re-
present the mean ± SEM of 4 biological replicates with 3 independent cell
donors.
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consistent with the induction of HCAEC death primarily by apoptosis on
prolonged exposure to 8ClA.
4. Discussion
There is increasing evidence for the formation of chlorinated nu-
cleosides in diﬀerent inﬂammatory pathologies [9,13–15]. This is at-
tributed to the overproduction of the MPO-derived oxidant HOCl,
which reacts readily with RNA and DNA, forming a range of stable
chlorinated products [2]. Whether these species play a role in pro-
moting the development of disease is less clear, though the presence of
chlorinated nucleobases in DNA is mutagenic (e.g. Ref. [18]) and has
been implicated as a key factor in the initiation of tumour growth in
inﬂammatory cancers [19,20]. This study examined the eﬀect of
chlorinated nucleosides on HCAEC, as MPO is a key driver of en-
dothelial damage in atherosclerosis [4], and there is evidence for the
presence of elevated levels of chlorinated nucleobases in human
atheroma [15].
The chlorinated ribose nucleotides 8ClA, 8ClG and 5ClC are in-
corporated into cellular RNA, whereas the chlorinated deoxyribose
nucleotides 8CldA, 8CldG and 5CldC, are incorporated into DNA of
HCAEC. The lack of incorporation of the chlorinated ribose nucleosides
into DNA supports previous data showing that ribonucleotide reductase
displays a lack of aﬃnity for chlorinated nucleotides [14,24]. However,
this may be cell type speciﬁc, as there is evidence for the incorporation
of 8ClA into the DNA of human gliomal cell lines for example [39]. In
general, the accumulation of each chlorinated nucleoside increased
with incubation time, reaching a maximum level after 24–48 h. It has
been shown previously that 5Cl(d)C and 8Cl(d)G can penetrate cells to
accumulate in the nucleotide pool of the EA.hy926 endothelial cell line,
though in this case, only incorporation of 5ClC was evident in the RNA
[14]. This contrasts with our ﬁndings in HCAEC, and may reﬂect the
diﬀerence between primary cells used in the present study, compared to
an immortalised cell line. In support of this notion, the penetration of
chlorinated nucleosides into primary epithelial prostatic cells is re-
ported to be 40–227 times higher than in the EA.hy926 cells [14]. Thus,
the incorporation of 8ClA into the cellular RNA agrees well with studies
performed in various malignant cell types [24,26].
The clearance of chlorinated nucleosides from the RNA and DNA
was examined by re-culturing the cells for 48 h in the absence of each
modiﬁed nucleoside after an initial 24 h incubation period. Under the
re-incubation conditions, a signiﬁcant decrease in 8ClA in the RNA was
observed, whereas there was no signiﬁcant diﬀerence in the con-
centration of 5ClC and 8ClG. With 8ClA, this may reﬂect the destabi-
lisation of the RNA, owing to this nucleoside adopting a syn-rather than
anti-conformation, in accord with previous studies [24]. A decrease in
RNA stability has also been reported on incorporation of 5ClC in the
RNA of EA.hy926 endothelial cells [14]. With HCAEC, although there
was a decrease in the concentration of 5ClC in the RNA, the change was
non-signiﬁcant, though this could reﬂect the variation in the levels of
incorporation that were seen between the diﬀerent cell donors tested
here.
With the deoxyribose chlorinated nucleosides, a decrease in the
concentration of each modiﬁed nucleoside in the DNA was seen, par-
ticularly with 8CldG and 5CldC, which were both initially incorporated
into the DNA to a higher extent compared to 8CldA. This is likely to
reﬂect some diﬀerences between the ability of the chlorinated nucleo-
sides to either penetrate the cells or to be recognised by DNA poly-
merases and/or ribonuclease reductase for incorporation into the DNA,
particularly in the case of 8CldG. A limitation of the current study is
that the concentration of chlorinated species in the cellular nucleotide
pool was not assessed, but previous reports are consistent with a greater
uptake of 8CldG in both endothelial and epithelial prostatic cells [14].
Whether there are diﬀerences in the ability of DNA polymerases to
recognise chlorinated nucleotides has not been examined in detail,
though 5CldC is reported to be incorporated into DNA in a non-cellular,
model system more readily than 8CldG [14]. Similarly, the cellular
pathways responsible for the removal of chlorinated nucleosides from
the DNA are not clear. The decrease in 5CldC within the DNA under the
re-incubation conditions could also reﬂect deamination to uracil, rather
than clearance, which may be mediated by cytidine deaminase or dCMP
deaminase [40].
Although all the chlorinated nucleosides incorporated into RNA or
DNA, a signiﬁcant diﬀerence in metabolic activity was only apparent in
experiments with 8ClA. The decrease in metabolic activity occurred
over a similar time period to the accumulation of 8ClA within the nu-
cleotide pool as 8Cl-ATP, and was associated with a decrease in gly-
colysis, rather than altered mitochondrial respiration, concomitant with
apoptotic cell death. 8ClA is a potent inducer of apoptosis in multiple
cancer cell lines, which has led to its use as a therapeutic agent for the
Fig. 5. The eﬀect of 8ClA on glycolysis
and GAPDH activity. HCAEC
(3.2× 104 cells) were treated with 8ClA (4,
8, 16 μM) or adenosine (16 μM) for 48 h
before assessing: A,B) basal glycolytic rate
using a Seahorse XF analyser to measure
ECAR following injection of glucose
(10mM), C) the concentration of extra-
cellular L-lactate and D) GAPDH activity.
The results represent the mean ± SEM of 4
biological replicates with 3 independent cell
donors. * (p < 0.05), ** (p < 0.01), ***
(p < 0.001), **** (p < 0.0001) represent
a signiﬁcant decrease compared to control
samples analysed using a one-way ANOVA
with Dunnett's multiple comparison post-
hoc test.
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treatment of chronic lymphocytic leukemia. In general, the mechanism
of cell death has been proposed to be through the formation of 8Cl-ATP
and depletion of ATP [22,28,41]. However, cell death in malignant cells
can also result from alterations in cellular signalling, leading to the
inhibition of transcription of anti-apoptotic proteins [22] or autophagy
[28].
The autophagic cell death reported in breast cancer cell lines is
caused by the activation of the AMP activated protein kinase (AMPK),
which is induced by the depletion of endogenous ATP on exposure of
the cells to 8ClA [28]. In this case, activation of AMPK attenuated
mTOR signaling to result in the phosphorylation of the autophagy
factor, Unc51-like kinase 1 [28]. Evidence for the activation of AMPK
was also obtained in experiments with 8Cl-cAMP, where again, a
marked decrease in ATP is apparent [27]. Whether AMPK is activated in
HCAEC exposed to 8ClA remains to be established. However, although
a marked increase in the accumulation of 8Cl-ATP was apparent in
HCAEC, the concentrations of ATP were only decreased on prolonged
treatment (48 h) with 8ClA. This is in contrast to the case with malig-
nant cells, where in general, a more rapid and pronounced decrease in
endogenous ATP levels are observed [25,28]. With the HCAEC, the loss
of ATP may be associated with an ability of 8ClA to compromise energy
production by glycolysis, shown by a decrease in ECAR, lactate pro-
duction, and GAPDH activity, as there was no evidence for altered
mitochondrial respiration. The perturbation of glycolysis on exposure
of cells to 8ClA has been reported previously [28]. In this case, the
decrease in glycolysis was attributed to altered glucose uptake, and
occurred together with a decrease in basal mitochondrial respiration,
which is in contrast to the current data with HCAEC.
However, treatment of HCAEC with 8ClA altered stress-related
cellular signalling cascades, with strong evidence to support the in-
duction of ER stress and the activation of the UPR, which may be re-
sponsible for the apoptotic cell death observed with these cells. The
pathway responsible for triggering ER stress in this case is not clear, but
may be related to the dysregulation of cellular bioenergetics observed
on treating HCAEC with 8ClA, given the central role of the ER in me-
tabolism. Activation of the UPR is intended to restore cellular home-
ostasis and promote cell survival, but prolonged ER stress triggers
apoptosis and the activation of additional stress responses within the
cells [35]. Our data are consistent with activation of both the PERK and
IRE1 branches of the UPR, resulting in the nuclear translocation of
ATF4, and the increased expression of GADD34 and the transcription
factor CHOP, which promotes cell death via apoptosis [38].
Evidence was also obtained in support of the activation of the
transcription factor Nrf2, with a signiﬁcant increase in the expression of
several Nrf2-associated antioxidant genes, including NQO1, HO-1 and
GCLC, observed in HCAEC treated with 8ClA. This may be a
Fig. 6. 8ClA treatment induces ER stress and
activation of the UPR. HCAEC (1× 105 cells)
were treated with 8ClA or adenosine (8 μM) for
6 h (panel A) or 24 h (panels B–E) before as-
sessing markers of ER stress. (A,B) Western blot
analysis of nuclear extracts showing transloca-
tion of ATF4 from the cytosol into the nucleus
compared to treatment with tunicamycin (Tun;
2.5 μg/mL). Graphs (C–F) show the mRNA ex-
pression of ATF4, GADD34, CHOP and sXPB1 at
24 h, as analysed by qRT-PCR with normal-
isation to the expression of the housekeeping
genes 18S and RPL13. Results represent the
mean ± SEM of 3 biological replicates with 3
independent cell donors and are expressed as an
increase relative to the non-treated control. **
(p < 0.01) and **** (p < 0.0001) represent a
signiﬁcant increase compared to control using a
one-way ANOVA with Dunnett's multiple post-
hoc comparisons test.
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consequence of the induction of ER stress, as PERK can phosphorylate
Nrf2, which promotes its dissociation from Keap1 [35]. Similarly,
treatment of HCAEC with 8ClA increases the expression of TXNIP,
which plays a vital role in the regulation of glucose metabolism, to-
gether with regulating the activity of protein disulphide isomerases
[42]. TXNIP increases the activity of ER resident protein disulphide
isomerases, to promote protein folding. Therefore, the induction of ER
stress has been shown in a number of cell types to elevate TXNIP ex-
pression [43,44]. The overexpression of TXNIP is also linked to pro-
apoptotic activity and redox stress [43], which may contribute to the
HCAEC cell death in this study.
Taken together, our results demonstrate that 8ClA is detrimental to
HCAEC survival and homeostasis, by perturbing cellular metabolism
and inducing ER stress and the upregulation of antioxidant and stress
responses, culminating in apoptotic cell death. ER stress is a char-
acteristic of both early and late lesions in atherosclerosis, and is a key
pathway to endothelial dysfunction [32,34]. Whether 8ClA is present in
suﬃciently high concentration at inﬂammatory sites to induce this ef-
fect requires further investigation. However, it is notable that com-
parable concentrations of 8ClA (and other chlorinated nucleosides) are
formed in cells exposed to pathologically-relevant concentrations of
HOCl [11,36]. This suggests that 8ClA may be able to contribute pa-
thologically during chronic inﬂammation, in addition to providing a
potential biomarker for disease diagnosis. Furthermore, it is important
to note that 8ClA exerts these cellular eﬀects on HCAEC at concentra-
tions comparable to the plasma levels achieved therapeutically in pre-
vious intervention studies [29] and clinical trials with the related
analogue 8Cl-cAMP [30], which is reported to have the same me-
chanism of action [26]. This raises questions as to the wider implica-
tions of the use of 8ClA on the vasculature for example, in a che-
motherapeutic context.
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Fig. 7. 8ClA alters the expression of cellular
antioxidant responses in HCAEC. HCAEC
(1× 105 cells) were treated with 8ClA or ade-
nosine (8 μM) for 24 h before assessing the ex-
pression of antioxidant genes or proteins.
Graphs (A–D) show the mRNA expression of
NQO1, HO-1, GCLC and TXNIP at 24 h, as ana-
lysed by qRT-PCR with normalisation to the
expression of the housekeeping genes 18S and
RPL13. Panels E and F show the alteration in
expression of TXNIP protein by Western blot-
ting, normalised to the expression of β-actin.
Results represent the mean ± SEM of 3 biolo-
gical replicates with 3 independent cell donors
and are expressed as an increase relative to the
non-treated control. * (p < 0.05) and **
(p < 0.01) represent a signiﬁcant increase
compared to control using a one-way ANOVA
with Dunnett's multiple post-hoc comparisons
test.
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